The effects of new synthetic antibacterial agents – tris(1-pentyl-1H-indol-3-yl)methylium chloride
(LCTA-1975) and (1-(4-(dimethylamino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-1H-indol-3-yl)bis(1-propyl-
1H-indol-3-yl)methylium chloride (LCTA-2701 – on model lipid membranes were studied. The ability of
the tested agents to form ion-conductive transmembrane pores, influence the electrical stability of lipid
bilayers and the phase transition of membrane lipids, and cause the deformation and fusion of lipid vesicles
was investigated. It was established that both compounds exert a strong detergent effect on model membranes.
The results of differential scanning microcalorimetry and measuring of the threshold transmembrane voltage
that caused membrane breakdown before and after adsorption of LCTA-1975 and LCTA-2701 indicated that both
agents cause disordering of membrane lipids. Synergism of the uncoupling action of antibiotics and the
alkaloid capsaicin on model lipid membranes was shown. The threshold concentration of the antibiotic that
caused an increase in the ion permeability of the lipid bilayer depended on the membrane lipid composition.
It was lower by an order of magnitude in the case of negatively charged lipid bilayers than for the uncharged
membranes. This can be explained by the positive charge of the tested agents. At the same time, LCTA-2701 was
characterized by greater efficiency than LCTA-1975. In addition to its detergent action, LCTA-2701 can induce
ion-permeable transmembrane pores: step-like current fluctuations corresponding to the opening and closing of
individual ion channels were observed. The difference in the mechanisms of action might be related to the
structural features of the antibiotic molecules: in the LCTA-1975 molecule, all three substituents at the
nitrogen atoms of the indole rings are identical and represent n-alkyl (pentyl) groups, while LCTA-2701
contains a maleimide group, along with two alkyl substituents (n-propyl). The obtained results might be
relevant to our understanding of the mechanism of action of new antibacterial agents, explaining the
difference in the selectivity of action of the tested agents on the target microorganisms and their
toxicity to human cells. Model lipid membranes should be used in further studies of the trends in
the modification and improvement of the structures of new antibacterial agents.